GLP-1 Advisor | One Day MD

Last updated: October 12, 2026 | Editorial review: OneDayMD Editorial Team GLP-1 alternatives include non-GLP-1 prescription weight-loss medicines, structured nutrition and exercise programs, behavioral treatment, and, for eligible people, metabolic and bariatric surgery. Some supplements may help fill nutritional gaps, but most products marketed as natural weight-loss drugs have not demonstrated effects comparable to prescription obesity medications. If you are considering an alternative to Ozempic, Wegovy, Mounjaro or Zepbound, start by identifying why you want to switch. Your best option may depend on cost, side effects, injection preferences, medical history, blood sugar control, and the amount of weight you need to lose. Key takeaway: Among established non-GLP-1 prescription options, phentermine/topiramate has demonstrated comparatively substantial weight loss in clinical evidence, but it is unsuitable for some people and requires medical supervision. Orlistat ...

Updated: October 3, 2026  |  Evidence review: Human clinical trials, systematic reviews, regulatory labeling and longevity research Can Ozempic, Wegovy, Mounjaro or Zepbound slow aging? GLP-1-based medicines have moved far beyond the original weight-loss conversation. Large clinical trials have shown meaningful benefits for cardiovascular outcomes, kidney disease, obesity-related heart failure and obstructive sleep apnea. Those effects could translate into healthier aging for appropriately selected patients. But that is not the same as proving that GLP-1 drugs directly slow the biological aging process or extend the maximum human lifespan. As of 2026, that distinction remains critical. OneDayMD evidence position: GLP-1 medicines should currently be viewed primarily as treatments for obesity, type 2 diabetes and selected obesity-related diseases—not as established anti-aging or lifespan-extension drugs. The strongest longevity ...